New Delhi: Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC on January 26, the first of its kind in India, the company’s chairman, and managing director Krishna Ella said here on Saturday.
Interacting with students at the Indian International Science Festival in Bhopal, Ella also said that a home-grown vaccine against nodular skin disease in cattle, Lumpi-ProVacInd, is likely to be launched next month.
“Our nasal vaccine will be officially launched on January 26, Republic Day,” said Ella, who is participating in the ‘Face-to-Face with New Frontiers in Science’ segment of the IISF, organized at the Maulana Azad National Institute of Technology ( MANIT).
In December, Bharat Biotech announced that it would sell the intranasal vaccine at ₹325 per injection for government procurement and at ₹800 per injection for private vaccination centers.